Hypochondria can, in extreme cases, leave people unable to hold down a job or make it impossible for them to leave the house, ...

Thousands of men claim finasteride, a drug that many start taking in their 20s and 30s to avoid hair loss, has left them with ...

About SPC-15 SPC-15 is a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for the treatment of PTSD, anxiety, and other stress-induced affective disorders. SPC-15 is being developed ...

Long-term anxiety can be ameliorated through better self-regulation, including hypnosis and taking positive actions.

Groundbreaking research reveals that it's possible to isolate the therapeutic benefits of psychedelics from their ...

New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics.

The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market.

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Hims & Hers (HIMS) stock price remained on edge even after the fast-growing telehealth company published strong financial ...

Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication kits at $79 per month. Soaring demand for weight-loss drugs such as Wegovy ...

Hims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 32 cents in third-quarter 2024 against the year-ago period’s loss of 4 cents per share. The metric was in line with the ...